RobertNRajuMD

PubMed

• 27 citations
  A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer
  Allen Lee Cohn, Michael Lahn, Kristen E. Williams, Ann Cleverly, Celine Pitou, Sunil Kadam, Mark W. Farmen, Durisala Desaiah, R. N. Raju, Paul Conkling, Donald A. Rich...> ;International Journal of Oncology. 2014 Dec 1
• 24 citations
  R-CHOP with Iodine-131 Tositumomab Consolidation for Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL): SWOG S0433
  Jonathan W. Friedberg, Joseph M. Unger, W. Richard Burack, Ajay K. Gopal, Robert N. Raju, Auayporn Nademanee, Mark S. Kaminski, Hongli Li, Oliver W. Press, Thomas P. M...> ;British Journal of Haematology. 2014 Aug 1
• 88 citations
  A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients ...
  Jonathan W. Goldman, Robert N. Raju, Gregory A Gordon, Iman El-Hariry, Florentina Teofilivici, V. Vukovic, Robert Bradley, Michael D Karol, Yu Chen, Wei-Wei Guo, Takay...> ;BMC Cancer. 2013 Mar 25
• 27 citations
  Paired Tumor and Normal Whole Genome Sequencing of Metastatic Olfactory Neuroblastoma
  Glen J. Weiss, Winnie S. Liang, Tyler Izatt, Shilpi Arora, Irene Cherni, Robert N. Raju, Galen Hostetter, Ahmet Kurdoglu, Alexis Christoforides, Shripad Sinari, Angela...> ;Plos One. 2012 May 23
• 33 citations
  Randomized, phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage II...
  Mark A. Socinski, Robert N. Raju, Thomas E. Stinchcombe, Darren M. Kocs, Linda S. Couch, David Barrera, Steven R. Rousey, Janak K. Choksi, Robert M. Jotte, Debra A. Pa...> ;Journal of Thoracic Oncology. 2010 Dec 1
• 65 citations
  Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer.
  R.M. Eager, C.C. Cunningham, N. Senzer, Donald A. Richards, Robert N. Raju, B. Jones, M. Uprichard, J. Nemunaitis> ;Clinical Oncology. 2009 Aug 1
• Final results of a randomized phase II trial of pemetrexed (P) + carboplatin (Cb) ± enzastaurin (E) versus docetaxel (D) + Cb as first-line treatment of patients (pts)...
  Obasaju CK, Raju RN, Stinchcombe T, Couch LS, Jotte R, Kocs DM, Wang Y, Bromund J, Treat J, Socinski MA> ;J. Clin. Oncol.. 2009-05-20
• A prospective evaluation of quality of life (QOL) in a phase II trial of pemetrexed (P) plus carboplatin (Cb) ± enzastaurin (E) versus docetaxel (D) plus Cb as first-l...
  Raju RN, Socinski M, Stinchcombe T, Couch LS, Kocs DM, Jotte R, Wang Y, Bromund J, Marciniak M, Obasaju C> ;J. Clin. Oncol.. 2009-05-20
• 67 citations
  Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma
  Nicholas J. Di Bella, Raymond Taetle, Kathryn S. Kolibaba, Thomas E. Boyd, Robert N. Raju, David Barrera, Ernest W. Cochran, Philip Y. Dien, Roger M. Lyons, Peter J. S...> ;Blood. 2008 Nov 16
• 22 citations
  Pemetrexed in relapsed small-cell lung cancer and the impact of shortened vitamin supplementation lead-in time: results of a phase II trial.
  Mark A. Socinski, Robert N. Raju, Marcus A. Neubauer, David Smith, Donald A. Richards, Michael Savin, Robert L. Ruxer, Craig H. Reynolds, Feng Zhan, Jane Bromund, Ruqi...> ;Journal of Thoracic Oncology. 2008 Nov 1
• An open label phase I dose escalation study of ADH-1 in combination with chemotherapy in subjects with N-Cadherin expressing solid tumors.
  Raju RN, Alemany C, Basche M, Garbo LE, Richards DA, Smith DA, Stephenson JJ, Norris R, Lawton M, Peters W, Becerra CR> ;J. Clin. Oncol.. 2008-05-20
• Preliminary results of a randomized phase II trial of pemetrexed (P) + carboplatin (Cb) ± enzastaurin (ENZ) versus docetaxel (D) + Cb as first-line treatment of patien...
  Kocs DM, Raju RN, Socinski MA, Stinchcombe TE, Rousey SR, Barrera D, Wang Y, Bromund J, Treat J, Obasaju CK> ;J. Clin. Oncol.. 2008-05-20
• 4 citations
  Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium
  Thomas E. Hutson, Svetislava J. Vukelja, Daniel Atienza, Sanjay Awasthi, Robert Delaune, Margaret Deutsch, Philip Y. Dien, Thomas F. Gregory, Michael J. Kolodziej, Jos...> ;Investigational New Drugs. 2008 Jan 31
• 350 citations
  Randomized Phase III Study of Trastuzumab, Paclitaxel, and Carboplatin Compared With Trastuzumab and Paclitaxel in Women With HER-2–Overexpressing Metastatic Breast Ca...
  Nicholas J. Robert, Brian Leyland-Jones, Lina Asmar, R. J. Belt, Des Ilegbodu, David M. Loesch, Robert N. Raju, Elizabeth Valentine, Robert M. Sayre, Melody A. Cobleig...> ;Journal of Clinical Oncology. 2006 Jun 20
• Phase 2 trial of talabostat and docetaxel in patients with stage IIIb/IV NSCLC.
  Cunningham C, Richards D, Salgia R, Leonard R, Raju R, Arseneau J, Packer S, Gregoire L, Haltom E, Uprichard MJ> ;J. Clin. Oncol.. 2005-06-01
• 14 citations
  Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
  Marcus A. Neubauer, David Garfield, Paul R. Kuerfler, Robert N. Raju, Deborah L. Lindquist, Edward W. Soo, Myrna Khan, Kristi A. Boehm, Lina Asmar> ;Lung Cancer. 2005 Jan 1
• Randomized phase III study of trastuzumab, paclitaxel, and carboplatin versus trastuzumab and paclitaxel in women with HER-2 overexpressing metastatic breast cancer: A...
  Robert NJ, Leyland-Jones B, Asmar L, Belt RJ, Ilegbodu D, Loesch DM, Raju RN, Cobleigh M, Albain KS, Slamom DJ> ;J. Clin. Oncol.. 2004-07-15
• Results of a pilot trial of OSI-461 in patients with chronic lymphocytic leukemia.
  Reynolds CH, Raju RN, Vukelja SJ, Belt RJ, Hyman WJ, Boehm KA, Asmar L> ;J. Clin. Oncol.. 2004-07-15
• 1 citations
  ViVACCy—A Drug Schedule Based on G2 Blockade and Prolonged Infusion of Multiple Tubulin‐Binding Agents A Pilot Study
  Stanley E. Shackney, Reginald P. Pugh, Bernard L. Zidar, Robert N. Raju, Sheryl R. Simon, Roberta N. Mazur, John W. Mucenski> ;Cancer. 1990 Aug 1
• 17 citations
  Radiation-induced leiomyosarcoma of the great vessels presenting as superior vena cava syndrome.
  Kenneth S. Weiss, Bernard L. Zidar, Scott Wang, George J. Magovern, Robert N. Raju, Anthony R. Lupetin, Stanley E. Shackney, Sheryl R. Simon, Madhuri Singh, Reginald P...> ;Cancer. 1987 Sep 15
• 29 citations
  Pseudo-Gaucher cells in the bone marrow of a patient with Hodgkin's disease.
  Bernard L. Zidar, R J Hartsock, Robert E. Lee, R H Glew, K L LaMarco, R P Pugh, R N Raju, S E Shackney> ;American Journal of Clinical Pathology. 1987 Apr 1
• 28 citations
  Treatment of six cases of mesothelioma with doxorubicin and cisplatin.
  Bernard L. Zidar, Reginald P. Pugh, Lewis M. Schiffer, Robert N. Raju, Kalpana A. Vaidya, R. Lee Bloom, Donna G. Horne, Laurence H. Baker> ;Cancer. 1983 Nov 15
• Join now to see all